Collectively, these data demonstrate that USP7 stabilizes MGMT to promote TMZ resistance, thus suggesting that targeting USP7 may be a potential therapeutic strategy to overcome chemoresistance in GBM. This evidence concerns the gene MGMT and glioblastoma.